European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 327-332, October 2003

Brain neurosteroid changes after paroxetine administration in mice

  • Allon Nechmad

      Affiliations

    • Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus, Petah Tikva, Israel
    • Shalvata Mental Health, Hod-Hasharon, Israel
    • ,
  • Rachel Maayan

      Affiliations

    • Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus, Petah Tikva, Israel
    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • ,
  • Baruch Spivak

      Affiliations

    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Research Unit, Ness Ziona Mental Health Center, Ness Ziona, Israel
    • ,
  • Edward Ramadan

      Affiliations

    • Department of Surgery A, Rabin Medical Center, Campus Golda, Petach-Tikva, Israel
    • ,
  • Michael Poyurovsky

      Affiliations

    • Research Unit, Tirat Carmel Mental Health Center and Faculty of Medicine, Institute of Technology, Technion Haifa, Israel
    • ,
  • Abraham Weizman

      Affiliations

    • Laboratory of Biological Psychiatry, Felsenstein Medical Research Center, Beilinson Campus, Petah Tikva, Israel
    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Research Unit, Geha Psychiatric Hospital, Beilinson Campus, Petah Tikva, Israel
    • Corresponding Author InformationCorresponding author. Research Unit, Geha Psychiatric Hospital, P.O.B. 102, Petach-Tikva 49100, Israel. Tel.: +972-3-925-8290; fax: +972-3-924-1041.

Received 13 August 2002; accepted 7 January 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-977X(03)00015-4

doi:10.1016/S0924-977X(03)00015-4

European Neuropsychopharmacology
Volume 13, Issue 5 , Pages 327-332, October 2003

Article Tools

* Image Usage & Resolution